Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc CURLF


Primary Symbol: T.CURA

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Cannabis Show ‘Promising Potential As Anticancer Agents
View:
Post by blackspade799 on Oct 11, 2024 8:49am

Cannabis Show ‘Promising Potential As Anticancer Agents

Cannabis Compounds Show ‘Promising Potential As Anticancer Agents

To complete the review, nine researchers from universities in Pakistan, Portugal, Turkey, Saudi Arabia, Romania and South Korea conducted a comprehensive search of several online databases for scientific literature that investigated the association between cannabis and cancer. The authors’ search “focused on peer-reviewed articles, review articles, and clinical trials discussing the anticancer properties of cannabinoids.” To be included in the review, articles had to be written in English and contain information on “the mechanisms of action and clinical efficacy of cannabinoids in cancer.”

Through their analysis, which was published last month in the peer-reviewed journal Discover Oncology, the researchers determined that cannabinoids including delta-9 THC, cannabidiol (CBD) and cannabigerol (CBG) showed “promising potential as anticancer agents through various mechanisms.”

https://www.forbes.com/sites/ajherrington/2024/10/08/cannabis-compounds-show-promising-potential-as-anti-cancer-agents/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities